SHR-4394
- Generic Name
- SHR-4394
A Study of SHR-4394 Injection in Subjects With Prostate Cancer
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT06783829
- Locations
- 🇨🇳
West China Hospital of Sichuan University, ChengDu, Sichuan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath